Growth Metrics

Lemaitre Vascular (LMAT) Share-based Compensation (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Share-based Compensation for 16 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 20.53% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Dec 2025, up 19.15% year-over-year, with the annual reading at $7.8 million for FY2025, 19.15% up from the prior year.
  • Share-based Compensation for Q4 2025 was $2.1 million at Lemaitre Vascular, up from $1.7 million in the prior quarter.
  • The five-year high for Share-based Compensation was $2.1 million in Q4 2025, with the low at $684000.0 in Q4 2022.
  • Average Share-based Compensation over 5 years is $1.4 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Share-based Compensation dropped 22.8% in 2022, then skyrocketed 105.26% in 2023.
  • Over 5 years, Share-based Compensation stood at $886000.0 in 2021, then dropped by 22.8% to $684000.0 in 2022, then surged by 105.26% to $1.4 million in 2023, then increased by 23.86% to $1.7 million in 2024, then increased by 20.53% to $2.1 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $2.1 million, $1.7 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.